Clinical Techniques
Fluorescein Angiography
Unlock FRCOphth Part 1 Study Notes to access this content.
Get accessFluorescence: the property of emitting a longer wavelength light when stimulated by a shorter wavelength
- White light from the camera passes through a blue excitation filter
Blue light (wavelength of 490nm) is transmitted to the fundus and is absorbed by the fluorescein molecules in the retinal and choroidal vasculature
They are stimulated to emit yellow-green light (530nm)
Hot Topic
Both the excitation and fluorescence of fluorescein angiography are absorbed and scattered by retinal pigments meaning that structures deep to these tissues are poorly visualised
Macular xanthophyll may have a physiological role in limiting damage to the photoreceptors by protecting them from high energy short-wavelength light
- A yellow-green filter is placed to block blue light reflected from the eye
- The yellow-green light therefore reached the camera
- Fluorescein has a low molecular weight
Can pass between endothelial cells in the choriocapillaris and other capillary beds in the body (therefore, in other tissues it does not stay intravascular)
The RPE tight junctions normally prevent this leak into the neural retina (outer barrier)
The tight junctions between retinal vascular endothelial cells also prevent leak normally (inner barrier)
- Fluorescein is 80-85% bound to serum protein (it is primarily hydrophilic)
- Leaks readily from fenestrated choriocapillaris
- 10% concentration fluorescein is used
- Anaphylactic shock: <1 in 100,000 (<0.001%)
- More common side effects
- Discolouration of skin and urine
- Nausea and vomiting
- Urticarial rash
- Flushing
- Photosensitivity
- Itch
- Discomfort at injection site
- The diameter of retinal vessels on FFA is larger than that of a fundus photograph
A photo only visualises the axial blood column whereas fluorescein reaches the peripheral blood in the vessel
Uses
- Diagnosis
- AMD
- CSR
- CMO
- Diabetic retinopathy
- Retinal vein occlusion
- Posterior uveitis
- Disc drusen
- Choroidal haemangiomas
- Management
- To guide laser in CNV, CSR, diabetic maculopathy and vein occlusion
Normal phases
- Choroidal: 10-12 seconds after injection in young patients but depends on vascular health
Hot Topic
A cilioretinal artery, if present, is a branch of the short posterior ciliary artery so fills during the choroidal phase
- Arterial: 1-3 seconds after the choroidal phase
Neovascularisation of the disc (part of the retinal circulation) is visible during the early arterial phase
The central retinal artery provides a circuitous route for the dye so it appears 1 or 2 seconds later than in the choroidal circulation
- Arteriovenous
Demonstrates laminar flow: the veins are fluorescent near their walls and darker centrally
- Lasts for 1-2 seconds
- Venous
- Late phase
- Highlights cystoid macular oedema, CSR, or occult subretinal neovascular membranes
- Late staining of the optic disc is normal
Abnormalities
Pooling: hyperfluorescence that increases in size and intensity as dye enters a closed space eg a pigment epithelial detachment
- Once the space is filled, the hyperfluorescence remains stable (cp leakage)
Leakage: increases in size and intensity of hyperfluorescence over time (due to extravasation of dye)
- Incompetence of the inner or outer blood-retinal barriers
- Neovascularisation: defective inner barrier
- Defective choroidal circulation eg. AMD
- Window defect: unmasking of the normal choroidal fluorescence
- RPE atrophy
- Window defects are seen early
- Staining: hyperfluorescence appears late. Uptake of dye into structures
- Drusen
- Disciform scars
- Optic disc
Pseudo-autofluorescence: overlap in the spectral transmission of the excitation and barrier filters
ICG
- Provides more information about the choroidal circulation
Hot Topic
ICG peak absorption (790-805nm) and fluorescence (770-880nm) are within the infrared range of wavelengths (>800nm) and thus can penetrate the overlying RPE, pigments and any overlying haemorrhages
ICG circulates 98% bound to plasma protein (it is amphiphilic, ie. both hydro- and lipophilic therefore binds lipproteins and phospholipids) so less leakage
Therefore provides information about the choroid that would be invisible to FFA due to extravasation of fluorescein from the choroid
- Takes longer than FFA
- Excreted by the hepatobiliary system: discoloured stool for several days
- Useful for
- Occult/poorly defined CNVM: can be more easily measured
- Polypoidal CNV
- Fibrovascular PEDs
- Medial opacities/vitreous haemorrhages
- Photophobic patients (they cannot see the infrared lights)
Inflammatory disease: to identify possibly occult choroidal disease (crucial investigation for inflammatory disease)
Summary Table: FFA findings of important pathologies table
Classic CNV | Well-delineated ‘lacy’ hyperfluorescence in early phasesAggressive/progressive leaking leads to dye pooling in subretinal space |
Occult CNV |
|
RAP | Early hyperfluorescence with progressive leakage |
PCV | ICG better: shows early subretinal hyperfluorescence <5 minutes |
CSR | Expansile dot (/ink-blot)Smoke-stack pattern |
CMO | Parafoveal leakage into petaloid pattern (cystoid spaces) |
Myopic CNV | Smaller than ARMD CNV with less subretinal/intraretinal fluid |
Angioid streaks | Hyperfluorescence due to window defect |
OIS | delayed/patchy choroidal filling, prolonged AV transit time, macular leakage/oedema, optic disc hyperfluorescence, retinal vascular staining (due to endothelial damage). Peripheral capillary non-perfusion |
Coats | Highlights abnormal vessels with leakage and areas of capillary dropout |
MacTel type 2 | Telangiectatic capillaries temporal to the fovea with early leakage. Signs of CNV if present |
Macroaneurysm | Immediate complete filling with late leakage |
Stargardt’s | Dark choroid due to blockage of choroidal fluorescence by abnormal deposits in RPE (of lipofuscin and A2E) |
Hydroxychloroquine toxicity | Windows defects due to RPE loss |
Capillary haemangioma | Rapid filling of a feeding artery followed by complete hyperfluorescence of the lesion, then filling of the vein and diffuse late leakage |
Cavernous haemangioma | Slow incomplete filling of lesion with fluid meniscus and no leakage |
Racemose haemangioma | Rapid filling with no leak |